Lifeway Foods/$LWAY

1D1W1MYTD1Y5YMAX

About Lifeway Foods

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
Ticker
$LWAY
Sector
Consumer Essentials
Primary listing
NASDAQ
Employees
294
Headquarters
Morton Grove, United States
Website
lifewaykefir.com

Lifeway Foods Metrics

BasicAdvanced
$319M
30.47
$0.69
0.46
-

What the Analysts think about Lifeway Foods

Analyst ratings (Buy, Hold, Sell) for Lifeway Foods stock.
Analyst projections of the future price of Lifeway Foods stock.

Bulls say / Bears say

Lifeway posted record second-quarter sales of $66.9 million, up 24.1%, and first-half sales rose 29.9%. This was its 27th consecutive quarter of year-on-year growth, pointing to sustained demand for its core products. (PR Newswire)
New placements at major retailers and food-service customers are widening Lifeway’s reach, while products such as Muscle Mates, Farmer Cheese and Kefir Butter extend the range beyond its flagship kefir. If these listings convert into repeat purchases, they could provide additional avenues for growth. (PR Newswire, Benzinga)
The Waukesha facility expansion is planned for completion in early 2027 and is intended to add capacity and improve operating efficiency. If delivered as planned, it could help Lifeway serve new retail and food-service demand while supporting future growth. (PR Newswire)
Growth has not translated into comparable earnings: second-quarter gross margin fell to 19.5% from 28.6%, and net income dropped to $0.1 million from $4.3 million. Elevated milk, packaging and transport costs are eroding the benefit of higher sales. (StockTitan)
The Waukesha project and other investment require substantial funding: Lifeway spent $19.5 million on capital expenditure in the first half and had about $22 million drawn on its revolving credit facility at June-end. Higher borrowing and a large construction programme increase financing and execution risk if the capacity does not earn an adequate return. (StockTitan, StockTitan)
First-half sales growth was driven primarily by higher volumes of branded drinkable kefir. That leaves Lifeway exposed if demand for its central product slows before newer lines become meaningful contributors. (StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2026.

Lifeway Foods Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Lifeway Foods Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Lifeway Foods News

AllArticlesVideos

Lifeway Foods Q2 Earnings Call Highlights

MarketBeat2 months ago

Funds containing Lifeway Foods

AllEURGBP
Funds
Fund name
Fund size
$LWAY weighting
SPDR Russell 2000 US Small Cap€R2US
€4.8B0.00%
SPDR Russell 2000 US Small Cap£R2SC
£4.1B0.00%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.